Press Release Aisa Pharma Announces Encouraging Results from Phase 2 RECONNOITER Trial of AISA-021 (Cilnidipine) in Patients with Systemic Sclerosis-Associated Raynaud’s Phenomenon 6 March 2026
Press Release HIMSS 2026: Artera to Showcase Real-World Applications of AI for Patient Communications and Access 6 March 2026
Press Release Trumid Reaches New ADV Milestone in February Amid Record Client Engagement 6 March 2026
Press Release U.S. FDA Approves TECVAYLI® in Combination with DARZALEX FASPRO® for Relapsed/Refractory Multiple Myeloma 6 March 2026
Press Release DiligenceSquared Raises $5M to Bring AI-Driven Commercial Due Diligence to Private Equity 6 March 2026
Press Release Enhans Launches Global Agentic AI Campaign with Lee Sedol in New York Times Square 6 March 2026
Press Release Intensity Therapeutics Regains Compliance with Nasdaq’s Minimum Bid Price Requirement 6 March 2026
